Icahn School of Medicine at Mount Sinai
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Icahn School of Medicine at Mount Sinai sits in the top decile of US sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count).
Icahn School of Medicine at Mount Sinai: 708 sponsored US clinical trials, 163 recruiting.
Icahn School of Medicine at Mount Sinai sponsors 708 registered US clinical trials on ClinicalTrials.gov, 163 of them currently recruiting, and 423 completed. 88 of these trials are in Phase 3-4 (later-stage) and 138 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 7 trials.
Top-decile sponsor footprint
Icahn School of Medicine at Mount Sinai ranks in the top decile of sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
423 of 499 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
708 total, page 7 of 15
Mindfulness Rounds Initiative - A Short Mindfulness-Based Program for A Busy Workplace
NCT04282733
Combined IV and Topical TXA in Major Spine Surgery
NCT04797156
Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP)
NCT04421079
Healthy Mediation Adherence To Transform and Effectively Relieve Symptoms
NCT04656093
Music as a Nonpharmacologic Approach to Pain Control With Intrauterine Device Placement
NCT04835701
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
NCT04720105
The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19
NCT04619680
Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy
NCT04272086
Community Interest in Vision Screening Technology
NCT04980430
Self-Control in Bulimia Nervosa
NCT04409457
Comprehensive Self-management Support for COPD Patients
NCT04533412
Assessing Inflammatory and Behavioral Pathways Linking PTSD to Increased Asthma Morbidity in WTC Workers
NCT04552301
TEEN HEED: An Adolescent Diabetes Prevention Intervention Incorporating Novel Mobile Health Technologies
NCT05560386
COVID-19 Anosmia Study
NCT04495816
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment
NCT04263090
Abdominal Binder and Steps Trial
NCT04414384
Treatments of Mal de Debarquement Syndrome (MdDS) by Habituation of Velocity Storage
NCT04213079
Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
NCT04397939
Early CPAP in COVID-19 Confirmed or Suspected Patients
NCT04390191
MSCs in COVID-19 ARDS
NCT04371393
Pre-Exposure Prophylaxis in the Emergency Department
NCT04429971
Increasing African Immigrant Women's Participation in Breast Cancer Screening
NCT04450264
Remote Participation (Within USA) Trial of Sana Pain Reliever
NCT04280562
Comparing Vision Tests in a Virtual Reality Headset to Existing Analogues
NCT04714424
Kidney Disease After COVID-19
NCT05328986
Methodology Issues in a Tailored Light Treatment for Persons With Dementia
NCT01816152
Transabdominal Plane (TAP) Blocks for Inguinal Hernia Repairs
NCT05672680
Use of Perioperative Pain Blocks In Urological Surgery
NCT04426500
Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery
NCT04017442
Assessing the Effectiveness of an N-of-1 Platform Using Study of Cognitive Enhancers
NCT04056650
Real-time Biofeedback With 7-Tesla MRI for Treatment of Depression
NCT04138680
Asthma and Obesity: Pilot Study
NCT04113746
Exoskeletal-Assisted Walking in SCI Acute Inpatient Rehabilitation
NCT04221373
Impact of Clinician Virtual Human Interaction Training in Emotional Self-Awareness on Patients Suicidal Ideation and Suicide Crisis Syndrome
NCT04127292
Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)
NCT04666077
Nailfold Capillary Blood Flow With Latanoprost Bunod
NCT03949244
Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects
NCT04173962
Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility Trial
NCT04700033
Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma
NCT04284540
Realtime Streaming Clinical Use Engine for Medical Escalation
NCT04026555
High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population
NCT05342532
Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color
NCT03681470
Vaccination With Flt3L, Radiation, and Poly-ICLC
NCT03789097
LRRK2, GBA and Other Genetic Biomarkers in Eastern European (Ashkenazi) Jews With and Without Parkinson's Disease
NCT04668898
Symptom Perception
NCT03646669
NYCKidSeq: Incorporating Genomics Into Clinical Care of Diverse NYC Children
NCT03738098
Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer
NCT03329378
Truncal Blocks Versus Wound Infiltration for SICD
NCT04974762
Group Acupuncture Therapy With Modified Yoga
NCT04296344
Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2
NCT03933696
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 81 |
| Phase 3 | 21 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Icahn School of Medicine at Mount Sinai pipeline
163 recruiting of 708 indexed (23% open); 423 completed (60%).
Phase mix: 88 late (III/IV) vs 138 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Icahn School of Medicine at Mount Sinai: open-pipeline peers nationwide
Peers matched on 708 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Icahn School of Medicine at Mount Sinai sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 708 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
- University of Miami · 721 trials · 20% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Icahn School of Medicine at Mount Sinai page
708 registered trials is a research-attention snapshot, not an endorsement of Icahn School of Medicine at Mount Sinai or any single study.
- 163 of Icahn School of Medicine at Mount Sinai's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Icahn School of Medicine at Mount Sinai studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Icahn School of Medicine at Mount Sinai pipeline card: 708 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.